前收市價 | 9.47 |
開市 | 6.92 |
買盤 | 6.90 |
賣出價 | 10.50 |
拍板 | 330.00 |
到期日 | 2024-05-17 |
今日波幅 | 6.79 - 7.27 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 214 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.